Informazio gehiago ― Euskalduna

Urticaria normalean azkura biziko zurrunbilo altxatuak agertzen dira; batzuetan, azpiko ehunen hanturarekin batera agertzen dira. Tratamenduak, ahal bada, eragileak saihestea du helburu. Lehen lerroko botikak antihistaminiko berriak barne hartzen ditu, behar izanez gero dosi handiagoetara egokitu daitezkeak. Laguntza gehigarri gisa, antihistaminiko zaharragoak, H2 blokeatzaileak, leukotrienoen hartzaileen antagonistak, antihistaminiko indartsuagoak eta kortikoideen ikastaro laburrak bezalako beste botika batzuk ere erabil daitezke. Neurri hauek izan arren, urtikariak irauten duten kasuetan, pazienteak espezialistetara bideratu behar dira, adibidez, omalizumab edo cyclosporine terapia osagarri gisa.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Berrikuspen honek urtikaria tratatzeko azken jarraibideak zehazten ditu eta kausen ulermen berriak eskaintzen ditu.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids